Impact of time to chest closure on early and late survival in adults with delayed sternal closure.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
03 02 2023
Historique:
received: 26 08 2022
revised: 10 01 2023
accepted: 06 02 2023
pubmed: 8 2 2023
medline: 18 2 2023
entrez: 7 2 2023
Statut: ppublish

Résumé

Delayed sternal closure (DSC) after cardiac surgery is a temporizing measure to address coagulopathy or haemodynamic instability after cardiac surgery. We sought to study: (i) indications and temporal trends for DSC, (ii) factors associated with time to chest closure and (iii) its impact on short-term and long-term outcomes. From January 2007 to December 2017, 494 patients (median age 67 years, 66% males) required DSC after cardiac surgery. Medical records were reviewed for indications, risk factors, time to DSC and outcomes. Multivariable Cox regression via landmark analysis of 486 5-day survivors was used to investigate the impact of time to chest closure on early and late survival. Coagulopathy and haemodynamic instability were the most common indications. Median time to chest closure was 2 days. Pre-/intraoperative extracorporeal membranous oxygenation, severe right ventricular dysfunction and diabetes mellitus were associated with longer time to chest closure. Longer time to closure was associated with increased risk of operative complications and operative mortality, but did not have a statistically significant association with late mortality. Increasing age, pulmonary hypertension and a greater number of prior sternotomies were also found to be associated with overall mortality. While longer time to chest closure was associated with increased rates of operative complications and operative mortality, it did not reveal a statistically significant association with long-term survival.

Identifiants

pubmed: 36749008
pii: 7030692
doi: 10.1093/ejcts/ezad044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Juan A Crestanello (JA)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Kevin Greason (K)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Mohamed Elsisy (M)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Brian Lahr (B)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Gabor Bagameri (G)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Richard Daly (R)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

John Stulak (J)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Joseph Dearani (J)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Hartzell Schaff (H)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH